Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors

By Gold Jason   Zwan Sanne   Gönen Mithat   Maki Robert   Singer Samuel   Brennan Murray   Antonescu Cristina   DeMatteo Ronald  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 134-142

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 601-606

Science Publishers

Access to resources Recommend Favorite

Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

By Yasuda Yosuke   Saito Kazutaka   Yuasa Takeshi   Kitsukawa Shinichi   Urakami Shinji   Yamamoto Shinya   Yonese Junji   Takahashi Shunji   Fukui Iwao  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 884-889

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors in Pediatric Malignancies

By Skolnik Jeffrey   Adamson Peter  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 606-612

Informa Healthcare

Access to resources Recommend Favorite

Cardiotoxicity induced by tyrosine kinase inhibitors

By Orphanos George   Ioannidis George   Ardavanis Alexandros  

Acta Oncologica, Vol. 48, Iss. 7, 2009-10 ,pp. : 964-970

Informa Healthcare

Access to resources Recommend Favorite